Provider review · Updated September 29, 2026
Found semaglutide offer review: the microdose page is not the whole agreement
The explicit compounded offer, broader price promotions and platform subscription describe different parts of Found’s service.
Editorial document research. No clinician review or firsthand treatment experience claimed.
A dedicated product page can name a treatment without establishing the commercial agreement for it. Found's microdosing page identifies compounded semaglutide, while broader pages discuss prices, promotions and subscriptions. A reader should not have to assume that every number elsewhere on the website belongs to that particular offer. The medicine description and selected plan need to meet in a specific record.
Plain Dose Language reviewed Found's official offer, microdosing page and relevant terms on September 29, 2026. We did not complete an assessment, enter checkout or identify a dispensing pharmacy. The published service is relevant to this topic because it explicitly advertises microdosing; that establishes an offer, not its efficacy or suitability.
The dedicated page supplies a category, not an examined formula
Found's microdosing page names compounded semaglutide and says a prescription depends on evaluation by a licensed provider. It also discloses that compounded GLP-1 products have not been reviewed by FDA for safety, effectiveness or quality and are not approved for a particular condition.
The word compounded does not reveal the complete formulation, added ingredients or pharmacy assigned to a patient. Our medicine terminology guide distinguishes those fields from an ingredient name. The reviewed page therefore supports a description of the advertised preparation category, while the actual prescription and pharmacy record remain unexamined. Neither the program name nor an ingredient match fills that gap.
Broader promotions are not a microdose quote
Found's homepage offer terms combine different promotions: annual-prepaid discounts on compounded medicines, certain first-checkout discounts supporting branded prescriptions, and exclusions for other plans. They also distinguish medication cost from subscription and clinical-care fees. These qualifications should stay beside the particular offer they describe.
We have not established that a homepage starting figure or annual saving applies to the dedicated microdose service. There is no reason to manufacture a total by selecting one medicine price and another membership promotion. The useful missing document is the selected agreement naming this program, its included services, total payment, commitment and renewal conditions together.
A subscription fee and medical care are not identical
The general terms describe a platform subscription that supports navigation, digital tools and other personal services. They expressly say payment of that subscription fee is not required to receive services from the Medical Groups, and describe an alternative way to ask about accessing medical care.
That does not prove that every advertised bundle is available on identical terms without membership. It identifies a separation between organizations and services that a chosen plan should explain. Calibrate's review examines a different program structure, where care fees, medicine and laboratory expenses also need separate identification despite appearing under one weight-management name.
Recurring payment does not describe what is dispensed
Under the subscription terms, charges recur at intervals described in the selected offer until cancellation. Plans can have different price levels, and some employer or other organizational arrangements may not impose the same subscription fee. A common website heading therefore does not establish a universal payment schedule for every member.
Our monthly-price guide makes a related distinction: the period bought by a payment cannot determine a prescription amount or shipment contents. Found's public terms do not let this review authenticate an individual preparation, shipment or invoice. The fact that a fee renews says something about the agreement, not about a patient's clinical continuation decision.
Cancellation can affect access before a refund is settled
Found's cancellation section says a request becomes effective within twenty-four hours. It also reserves the possibility of immediately deactivating platform access and says access to providers and prescription medication is suspended on cancellation. Fees or costs incurred before the effective cancellation remain relevant.
These provisions explain why cancellation is more than a change to a marketing preference. They do not give a medical discontinuation plan. Any continuity question belongs with the treating professionals. Henry Meds' review contrasts another documented arrangement, with a specific advance-renewal notice period and different language about access through the paid period.
Refund discretion is not a promised personal remedy
Found's terms generally make subscription fees final and nonrefundable unless stated otherwise, to the extent permitted by law. They reserve discretion to issue a credit or refund without creating a future obligation to do the same. The subscription's existence therefore does not establish a refundable medicine order, and a cancellation request does not prove that money will be returned.
The selected plan could carry additional conditions that were not verified here. We report the general rule without deciding its application to an individual's contract or legal rights. A provider's administrative answer also cannot determine whether treatment has worked or whether a formulation is appropriate for continued clinical use.
Preventive language needs a different kind of evidence
The microdose offer describes metabolic, hormonal and other potential benefits. Those are provider claims, not proof that the exact finished compound has demonstrated each effect. FDA's compounding explanation also distinguishes compounds from approved generic drugs; shared ingredient language cannot supply an approval record that does not belong to the preparation.
The offer-record comparison keeps those clinical questions apart from billing clarity. Found has an identifiable compounded offer and published service terms, but this review has not verified an exact formula, pharmacy, selected price or personal refund. Keeping those limits visible makes the documents more useful without turning a subscription into a treatment recommendation.
Sources for this article
- Found — compounded-semaglutide microdosing offer ↗Official prescription-conditional compounded offer and proposed health benefits; no FDA approval or examined patient-specific formulation. Advertised benefits do not establish matching finished-product outcomes. · Checked 2026-09-29
- Found — weight-care programs and promotional terms ↗Official broader branded and compounded program with distinct prepaid discounts and exclusions; homepage promotions do not establish a selected microdose price or pharmacy. · Checked 2026-09-29
- Found — terms and conditions, updated November 13, 2024 ↗Official platform/medical-group distinction, subscription fees, cancellation within 24 hours, possible immediate access loss and qualified nonrefundability; additional selected-plan terms remain unverified. · Checked 2026-09-29
- FDA — compounded drugs, generic drugs and product oversight ↗Official distinction between compounded and approved generic products and between compounding settings; not a provider-specific defect, pharmacy audit or personal legal eligibility determination. · Checked 2026-09-29